Tele-epilepsy Market Size, Share & Trends Analysis Report By Patient Market (Pediatric, Adult), By Component (Hardware, Software, Service), By End-use, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global tele-epilepsy market size was valued at USD 0.32 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 15.7% from 2022 to 2030. The growing adoption of telemedicine services and solutions, favorable government programs for epilepsy in developed countries, rising epilepsy cases in adult and pediatric populations, increasing adoption of mobile and internet services, technological advancements, and reduction in the cost of treatment are factors driving the growth of the market for tele-epilepsy.

The ongoing COVID-19 pandemic significantly impacted hospitals that were overflowing with patients, placing a burden on the healthcare system. In addition, the increase in the inflow of patients during the COVID-19 pandemic for epilepsy has led to the use of telemedicine for communication purposes. Moreover, many government agencies are embracing telehealth by implementing new rules and reimbursement standards.

For instance, in February 2020, the Singapore Medical Association's telehealth professionals published guidelines on utilizing telemedicine during the time of increasing COVID-19 cases. Apart from this, they also released a fast guide for healthcare practitioners who are unaware of riding on a structure that is already up and running through 10 telehealth providers in the island state, in response to the rising use of telemedicine consults during the COVID-19 pandemic.

The number of epilepsy cases across the U.S. was 3.4 million (3 million adults and 4,70,000 children) in 2015. The high number has led to the implementation of government initiatives to promote the use of tele-epilepsy to facilitate effective and efficient care. For instance, in August 2020, the FCC launched a program to address health disparities, service provider issues, and advanced broadband services and technology in rural areas of the US.

The agencies aim to create an interstate Rural Telehealth Initiative Task Force, made up of representatives from each agency, to reduce the gap between teleconsultation. Moreover, increased funding for telemedicine start-ups by private players, and an increase in collaborations and partnerships, are the main factors driving the growth in this market.

Patient Market Insights

The adult patient segment held the largest market share of 57% in 2021, as a result of an increase in the adult population considering the severity. An adult suffering from epilepsy is at more risk of getting into severe conditions after seizures, which increases the role of tele-epilepsy. Based on patients, the tele-epilepsy market is segmented into pediatric and adult segments.

The pediatric segment is anticipated to expand at a CAGR of 15.6% during the forecast period. Epilepsy cases in children are different from those in adults, in the context of seizure type and epilepsy syndrome, as children have higher immunity levels and are less prone to other diseases. For instance, juvenile convulsions and epileptic syndromes like Lennox-Gastaut disorder, childhood absence epilepsy, and Dravet syndrome are frequently distinct in the pediatric population.

Component Insights

The hardware component held the largest share of over 41% in 2021, due to the extensive use of videoconferencing technology, audio equipment, microphones, and other medical accessories to support virtual visits. For instance, in March 2021, IVP Research Labs, Schlesinger Group, and Shimmer Research launched the official NeuroLynQ service process for central location studies. It offers a remote biometric tracking device that makes it possible to assess users' unconscious human emotions while they are home. Based on component, the market is segmented into hardware, service, and software.

The service segment is anticipated to progress at a CAGR of 16.4% during the forecast period from 2022 to 2030, owing to the growth of remote patient monitoring solutions. The segment growth will be fueled by the widespread usage of teleconsulting between patients and clinicians. For instance, in September 2019, Eagle Telemedicine announced the launch of TeleNocturnist and TeleHospitalist programs at the Jersey Community Hospital. This initiative will help expand the reach of the company’s services across rural locations in the U.S.

End-use Insights

The hospital segment accounted for a substantial revenue share of 34.2% in the market in 2021 and is expected to expand at a healthy CAGR of 15.7% during the forecast period. The growth is anticipated as hospitals are preferred by patients for their treatment process, in the context of convenience and variety of product offerings in one place. Moreover, hospitals are omnipresent and easily accessible to all patients. Based on end-use, the market is segmented into hospitals, payers, and healthcare consumers.

The healthcare consumer segment is poised to witness growth in the adoption of teleconsultation services because of the efficiency and effectiveness of online consultation, with the benefit of getting treatment in time of emergency from their place.

Regional Insights

North America dominated the market with a revenue share of 37.9% in 2021, owing to the technologically advanced infrastructure, rising number of epilepsy cases, and growing per capita income. In addition, presence of many market players and supporting government regulations in the region are boosting regional growth. For instance, in March 2020, The Federal Communications Commission in the U.S. developed initiatives to aid healthcare organizations in implementing telemedicine technology.

Asia Pacific is expected to expand at a CAGR of 16.6% during the assessment period, owing to the significant adoption of advanced technologies, enhanced network connectivity, rising incidence of epilepsy cases, and increased government program offerings.

For instance, in February 2022, the Myanmar WHO Program launched for Reducing the Epilepsy Treating Gap and the Psychiatric Gap Action Program succeeded in achieving these objectives. These initiatives aimed to improve the capacity of community-based primary care and non-specialist healthcare practitioners to identify, manage, and follow up on epilepsy patients. Due to the impact of these 4 pilot programs, 6.5 million people have received epilepsy treatment.

Key Companies & Market Share Insights

Key players operating in the tele-epilepsy industry are more concentrated on strategic collaborations with technology providers and product developments. Furthermore, they are implementing strategies such as mergers and acquisitions, product and service launches, agreements, joint ventures, collaborations, and expansions to strengthen their position in the market for tele-epilepsy.

In March 2021, IVP Research Labs, Schlesinger Group, and Shimmer Research launched the official NeuroLynQ service process for central location studies. This service is for at-home biometric neuroscientific research. The NeuroLynQ service offers a remote biometric tracking device that makes it possible to assess users' unconscious human emotions while they are at home. Major companies in the global tele-epilepsy market include:

• Shimmer

• Empatica

• SOC Telemed

• Eagle Telemedicine

• Sevaro

• Tele Specialists

• Chiron Health

• RTTC

• Science Soft USA Corporation

• Vidyo, Inc.

Tele-epilepsy Market Report Scope

Global Tele-epilepsy Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global tele-epilepsy market report based on patient market, component, end-use, and region:

•  Patient Outlook (Revenue, USD Million, 2017 - 2030)

  • Pediatric

  • Adult

• Component Outlook (Revenue, USD Million, 2017 - 2030)

  • Software

  • Hardware

  • Service

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals providers

  • Payers

  • Healthcare consumers

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Singapore

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE